Assessing inter-observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI-based method. [PDF]
Dionne P +10 more
europepmc +1 more source
Present status of prostate cancer diagnosis, limitations, challenges, and future endeavors. [PDF]
Hooda K +4 more
europepmc +1 more source
Integrating Multiparametric MRI and PSMA PET Imaging in Prostate Cancer: Toward a Unified Diagnostic and Risk-Stratification Paradigm. [PDF]
Pugliesi RA +4 more
europepmc +1 more source
Multiparametric MRI findings, PI-RADS scores, and gleason scores in prostate cancer patients at Kumasi, Ghana: a cross-sectional analysis. [PDF]
Ampah BA +9 more
europepmc +1 more source
Focal Signet Ring-Like Prostate Adenocarcinoma Detected on Microultrasound in the Setting of Negative Multiparametric Magnetic Resonance Imaging: A Case Report. [PDF]
Healey KD +5 more
europepmc +1 more source
Is Saturation Biopsy Still a Viable Alternative to Fusion Biopsy in the Era of Multiparametric MRI? A Comparative Analysis in Patients With Prior Negative Biopsy. [PDF]
Taşkıran AT, Şenoğlu Y.
europepmc +1 more source
Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends [PDF]
Prostate carcinoma is one of the most prevalent cancers worldwide. Multiparametric magnetic resonance imaging (mpMRI) is a non-invasive tool that can improve prostate lesion detection, classification, and volume quantification.
Peter Chang +2 more
exaly +2 more sources
The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI
Prostate cancer is the second most common cancer in men and a leading cause of death worldwide. Early detection is vital, as it often presents with vague symptoms such as nocturia and poor urinary stream.
Diana Manolescu +2 more
exaly +2 more sources
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer [PDF]
Background: Detecting carcinoma prostate (CaP) after intravesical Bacillus Calmette Guerin (BCG) immunotherapy for non-muscle invasive bladder cancer (NMIBC) poses diagnostic challenges.
Prabhakar, Pushan +4 more
exaly +2 more sources
Related searches:

